These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 1581897)
21. Effects of retinoic acid and gamma-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells. Widschwendter M; Daxenbichler G; Dapunt O; Marth C Cancer Res; 1995 May; 55(10):2135-9. PubMed ID: 7743514 [TBL] [Abstract][Full Text] [Related]
22. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines. Liu L; Gudas LJ J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002 [TBL] [Abstract][Full Text] [Related]
24. Retinoic acid metabolism and inhibition of cell proliferation: an unexpected liaison. Takatsuka J; Takahashi N; de Luca LM Cancer Res; 1996 Feb; 56(4):675-8. PubMed ID: 8630993 [TBL] [Abstract][Full Text] [Related]
25. Experimental studies with liarozole (R 75,251): an antitumoral agent which inhibits retinoic acid breakdown. De Coster R; Wouters W; Van Ginckel R; End D; Krekels M; Coene MC; Bowden C J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):197-201. PubMed ID: 1525060 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine. Strobl JS; Kirkwood KL; Lantz TK; Lewine MA; Peterson VA; Worley JF Cancer Res; 1990 Sep; 50(17):5399-405. PubMed ID: 2386945 [TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression. Rosenauer A; Nervi C; Davison K; Lamph WW; Mader S; Miller WH Cancer Res; 1998 Nov; 58(22):5110-6. PubMed ID: 9823320 [TBL] [Abstract][Full Text] [Related]
28. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258 [TBL] [Abstract][Full Text] [Related]
29. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth. Patel JB; Mehta J; Belosay A; Sabnis G; Khandelwal A; Brodie AM; Soprano DR; Njar VC Br J Cancer; 2007 Apr; 96(8):1204-15. PubMed ID: 17387344 [TBL] [Abstract][Full Text] [Related]
30. All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells. Li RJ; Ying X; Zhang Y; Ju RJ; Wang XX; Yao HJ; Men Y; Tian W; Yu Y; Zhang L; Huang RJ; Lu WL J Control Release; 2011 Feb; 149(3):281-91. PubMed ID: 20971141 [TBL] [Abstract][Full Text] [Related]
31. Liarozole inhibits human epidermal retinoic acid 4-hydroxylase activity and differentially augments human skin responses to retinoic acid and retinol in vivo. Kang S; Duell EA; Kim KJ; Voorhees JJ J Invest Dermatol; 1996 Aug; 107(2):183-7. PubMed ID: 8757760 [TBL] [Abstract][Full Text] [Related]
32. Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice. Patel JB; Huynh CK; Handratta VD; Gediya LK; Brodie AM; Goloubeva OG; Clement OO; Nanne IP; Soprano DR; Njar VC J Med Chem; 2004 Dec; 47(27):6716-29. PubMed ID: 15615521 [TBL] [Abstract][Full Text] [Related]
33. Induction of the oxidative catabolism of retinoid acid in MCF-7 cells. Krekels MD; Verhoeven A; van Dun J; Cools W; Van Hove C; Dillen L; Coene MC; Wouters W Br J Cancer; 1997; 75(8):1098-104. PubMed ID: 9099955 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity. Van Heusden J; Van Ginckel R; Bruwiere H; Moelans P; Janssen B; Floren W; van der Leede BJ; van Dun J; Sanz G; Venet M; Dillen L; Van Hove C; Willemsens G; Janicot M; Wouters W Br J Cancer; 2002 Feb; 86(4):605-11. PubMed ID: 11870544 [TBL] [Abstract][Full Text] [Related]
35. Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat model. Goss PE; Strasser-Weippl K; Qi S; Hu H BMC Cancer; 2007 Jan; 7():26. PubMed ID: 17266767 [TBL] [Abstract][Full Text] [Related]
36. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells. Sonneveld E; van den Brink CE; van der Leede BM; Schulkes RK; Petkovich M; van der Burg B; van der Saag PT Cell Growth Differ; 1998 Aug; 9(8):629-37. PubMed ID: 9716180 [TBL] [Abstract][Full Text] [Related]
37. Retinoic acid metabolism in cultured retinal pigment epithelial cells. Doyle JW; Dowgiert RK; Buzney SM Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):708-17. PubMed ID: 7890501 [TBL] [Abstract][Full Text] [Related]
38. All-trans-retinoic acid metabolites significantly inhibit the proliferation of MCF-7 human breast cancer cells in vitro. Van heusden J; Wouters W; Ramaekers FC; Krekels MD; Dillen L; Borgers M; Smets G Br J Cancer; 1998; 77(1):26-32. PubMed ID: 9459142 [TBL] [Abstract][Full Text] [Related]
39. Liarozole fumarate inhibits the metabolism of 4-keto-all-trans-retinoic acid. Van Wauwe J; Coene MC; Cools W; Goossens J; Lauwers W; Le Jeune L; Van Hove C; Van Nyen G Biochem Pharmacol; 1994 Feb; 47(4):737-41. PubMed ID: 8129749 [TBL] [Abstract][Full Text] [Related]
40. Modulation of all-trans retinoic acid pharmacokinetics by liarozole. Miller VA; Rigas JR; Muindi JR; Tong WP; Venkatraman E; Kris MG; Warrell RP Cancer Chemother Pharmacol; 1994; 34(6):522-6. PubMed ID: 7923564 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]